Literature DB >> 27105659

Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults.

M A Strom1, A B Fishbein2,3, A S Paller1,3,4, J I Silverberg5,6,7,8.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is associated with chronic itch, allergic disease and sleep disturbance, all of which might increase the risk of attention deficit (hyperactivity) disorder (ADD/ADHD). Previous analyses have found a consistent association between AD and ADD/ADHD, although the underlying factors contributing to such an association remain underexplored. Additionally, the relationship has been underexplored in adults.
OBJECTIVES: To determine if childhood and adult AD and AD severity are associated with ADD/ADHD and to delineate the factors contributing to such an association.
METHODS: We analysed data on 354 416 children aged 2-17 years and 34 613 adults age 18+ years from 19 U.S. population-based surveys, including the National Health Interview Survey 1997-2013 and the National Survey of Children's Health 2003/4 and 2007/8.
RESULTS: In multivariate models adjusting for age, sex, sociodemographics, allergic disease and healthcare utilization, AD was associated with ADD/ADHD in both children [adjusted odds ratio (95% confidence interval), 1·14 (1·03-1·26)] and adults [1·61 (1·25-2·06)]. Children with both severe AD and only 0-3 nights of adequate sleep per week had much higher odds of ADD/ADHD [16·83 (7·02-40·33)] than those with 0-3 nights of adequate sleep per week [1·83 (1·47-2·26)] or mild-moderate AD alone [1·56 (1·22-1·99)]. AD was most strongly associated with severe ADHD. AD unaccompanied by other allergic disease was also associated with increased risk of ADD/ADHD in children. Among children with AD, history of anaemia, headaches and obesity were associated with even higher odds of ADD/ADHD. Asthma, insomnia and headaches increased the odds of ADHD in adults with AD, although underweight body mass index was protective.
CONCLUSIONS: Atopic dermatitis is associated with increased odds of ADD/ADHD in adults and children. Several factors increase the risk of ADHD in adults and children with AD.
© 2016 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2016        PMID: 27105659      PMCID: PMC5216180          DOI: 10.1111/bjd.14697

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  46 in total

1.  Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents.

Authors:  Jochen Schmitt; Marcel Romanos; Natalie M Schmitt; Michael Meurer; Wilhelm Kirch
Journal:  JAMA       Date:  2009-02-18       Impact factor: 56.272

2.  Migraine, tension-type headache, and attention-deficit/hyperactivity disorder in childhood: a population-based study.

Authors:  Marco A Arruda; Vincenzo Guidetti; Federica Galli; Regina C A P Albuquerque; Marcelo E Bigal
Journal:  Postgrad Med       Date:  2010-09       Impact factor: 3.840

3.  Sensory processing patterns of adults with atopic dermatitis.

Authors:  B Engel-Yeger; D Mimouni; D Rozenman; A Shani-Adir
Journal:  J Eur Acad Dermatol Venereol       Date:  2010-06-17       Impact factor: 6.166

4.  Health Care Utilization, Patient Costs, and Access to Care in US Adults With Eczema: A Population-Based Study.

Authors:  Jonathan I Silverberg
Journal:  JAMA Dermatol       Date:  2015-07       Impact factor: 10.282

5.  Prevalence, Patient Characteristics, and Pharmacological Treatment of Children, Adolescents, and Adults Diagnosed With ADHD in Sweden.

Authors:  MaiBritt Giacobini; Emma Medin; Ewa Ahnemark; Leo J Russo; Peter Carlqvist
Journal:  J Atten Disord       Date:  2014-11-05       Impact factor: 3.256

6.  Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus).

Authors:  Jochen Schmitt; Christian Apfelbacher; Chih-Mei Chen; Marcel Romanos; Stefanie Sausenthaler; Sibylle Koletzko; Carl-Peter Bauer; Ute Hoffmann; Ursula Krämer; Dietrich Berdel; Andrea von Berg; H-Erich Wichmann; Joachim Heinrich
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

7.  Iron deficiency in children with attention-deficit/hyperactivity disorder.

Authors:  Eric Konofal; Michel Lecendreux; Isabelle Arnulf; Marie-Christine Mouren
Journal:  Arch Pediatr Adolesc Med       Date:  2004-12

8.  Association between childhood eczema and headaches: An analysis of 19 US population-based studies.

Authors:  Jonathan I Silverberg
Journal:  J Allergy Clin Immunol       Date:  2015-08-29       Impact factor: 10.793

9.  Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization.

Authors:  Jonathan I Silverberg; Eric L Simpson
Journal:  Pediatr Allergy Immunol       Date:  2013-06-16       Impact factor: 6.377

10.  Sleep disturbances in children with atopic dermatitis.

Authors:  R E Dahl; J Bernhisel-Broadbent; S Scanlon-Holdford; H A Sampson; M Lupo
Journal:  Arch Pediatr Adolesc Med       Date:  1995-08
View more
  30 in total

Review 1.  Selected comorbidities of atopic dermatitis: Atopy, neuropsychiatric, and musculoskeletal disorders.

Authors:  Jonathan I Silverberg
Journal:  Clin Dermatol       Date:  2017-03-24       Impact factor: 3.541

2.  Burden of skin pain in atopic dermatitis.

Authors:  Paras P Vakharia; Rishi Chopra; Ryan Sacotte; Kevin R Patel; Vivek Singam; Neha Patel; Supriya Immaneni; Takeshia White; Robert Kantor; Derek Y Hsu; Jonathan I Silverberg
Journal:  Ann Allergy Asthma Immunol       Date:  2017-12       Impact factor: 6.347

3.  Parent report of sleep health and attention regulation in a cross-sectional study of infants and preschool-aged children with atopic dermatitis.

Authors:  Nina Y Zhou; Amanda Nili; Courtney K Blackwell; Nonye Ogbuefi; Peter Cummings; Jin-Shei Lai; James W Griffith; Amy S Paller; Lauren S Wakschlag; Anna B Fishbein
Journal:  Pediatr Dermatol       Date:  2021-12-21       Impact factor: 1.997

4.  Mental health impairment among children with atopic dermatitis: A United States population-based cross-sectional study of the 2013-2017 National Health Interview Survey.

Authors:  Joy Wan; Junko Takeshita; Daniel B Shin; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2019-10-15       Impact factor: 11.527

5.  What are the highest yielding search strategy terms for systematic reviews in atopic dermatitis? A systematic review.

Authors:  Marissa T Ayasse; Adnan Ahmed; Maria L Espinosa; Christina J Walker; Muhammad Yousaf; Jacob P Thyssen; Jonathan I Silverberg
Journal:  Arch Dermatol Res       Date:  2020-11-22       Impact factor: 3.017

6.  Sleep Disturbance in School-Aged Children with Atopic Dermatitis: Prevalence and Severity in a Cross-Sectional Sample.

Authors:  Anna B Fishbein; Brian T Cheng; Caroline C Tilley; Wendy Smith Begolka; Adam C Carle; Christopher B Forrest; Phillis C Zee; Amy S Paller; James W Griffith
Journal:  J Allergy Clin Immunol Pract       Date:  2021-05-12

7.  Mental Health Symptoms and Functional Impairment in Children With Atopic Dermatitis.

Authors:  Brian T Cheng; Anna B Fishbein; Jonathan Ian Silverberg
Journal:  Dermatitis       Date:  2021 Sep-Oct 01       Impact factor: 4.845

8.  The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan.

Authors:  Vincent Chin-Hung Chen; Yao-Hsu Yang; Yin-To Liao; Ting-Yu Kuo; Hsin-Yi Liang; Kuo-You Huang; Yin-Cheng Huang; Yena Lee; Roger S McIntyre; Tzu-Chin Lin
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

Review 9.  Associations between atopic dermatitis and other disorders.

Authors:  Jonathan I Silverberg
Journal:  F1000Res       Date:  2018-03-12

10.  Attentional Bias Modification Training for Itch: A Proof-of-Principle Study in Healthy Individuals.

Authors:  Antoinette I M van Laarhoven; Jennifer M Becker; Dimitri M L van Ryckeghem; Stefaan Van Damme; Geert Crombez; Reinout W H J Wiers
Journal:  Front Med (Lausanne)       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.